Intelligence · Clinical Pipeline
Phase I Pipeline Programs
First-in-human and early clinical safety studies in Phase I.
- Programs
- 4,713
Quick answer
NovaPharmaNews tracks 4,713 phase i pharmaceutical pipeline programs from ClinicalTrials.gov. First-in-human and early clinical safety studies in Phase I.
Top sponsors
- BRIGHT MINDS BIOSCIENCES 327 programs
- Takeda 276 programs
- Anaxis Pharma 204 programs
- Chinese Academy of 190 programs
- United Therapeutics Europe 184 programs
- Teva Pharma 154 programs
- First People's Hospital 149 programs
- Regeneron UK 126 programs
- Boehringer Ingelheim 94 programs
- Sunshine Guojian Pharmaceutical 85 programs
- Lakefront Biotherapeutics NV 62 programs
- HOFFMANN-LA ROCHE 58 programs
-
A Study to Investigate the Effect of RO7504109 on Immune Cells in Healthy Participants
Hoffmann-La Roche
Not Applicable (N/A)
1 trial -
A Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Rilvegostomig in Adult Participants with Advanced Solid Tumors Previously Treated with Standard of Care Therapy
AstraZeneca AB
Advanced Solid Tumors
1 trial -
A Study to Investigate the Pharmacokinetics, Safety and Tolerability of AZD5462 in Participants with Renal Impairment
AstraZeneca AB
Impaired renal function
1 trial -
A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide to Hypoglycemia
Eli Lilly Co.
Type 2 Diabetes Mellitus
1 trial -
A Study to Investigate the Safety and Tolerability of Ziftomenib Combinations in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Kura Oncology
Relapsed and/or refractory Acute Myeloid Leukemia
1 trial -
A Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of Ascending Intravenous Doses of Glofitamab, Administered after Ocrelizumab Pretreatment, in Patients with Multiple Sclerosis
Hoffmann-La Roche
Multiple Sclerosis (MS)
1 trial -
A Study to Investigate the Safety, Tolerability, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of RO7121932 following Intravenous and Subcutaneous Administration in Participants with Multiple Sclerosis
Hoffmann-La Roche
Multiple Sclerosis (MS)
1 trial -
A Study to Learn About How Different Formulations of the Medicine Called Mevrometostat are Taken up Into the Blood in Healthy Adult Participants
Pfizer Australia Pty Ltd
Small cell lung cancer, Castration-resistant prostate cancer, Follicular lymphoma
1 trial -
A Study to Learn About if the Study Medicine Called Ibuzatrelvir changes how the body process the other Medicine Dabigatran Etexilate in healthy adults
Pfizer Australia Pty Ltd
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
1 trial -
A Study to Learn About the Study Medicine Called PF-07054894 in People of Japanese Origin
Pfizer Australia Pty Ltd
Inflammatory bowel disease
1 trial -
A Study to Learn About the Study Medicine Called PF-07258669 in Older Adults Including Those at Risk of Malnutrition
Pfizer Australia Pty Ltd
Older adults at risk of malnutrition
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07293893 are Tolerated and Act in the Body of Healthy Adults.
Pfizer Australia Pty Ltd
heart failure with preserved ejection fraction
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 are Tolerated and Act in the Body in Healthy Adults
Pfizer Australia Pty Ltd
Heart failure
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults
Pfizer Australia Pty Ltd
Clonal hematopoiesis
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07940369 are Tolerated and Act in the Body in Healthy Adults.
Pfizer Australia Pty Ltd
clonal hematopoiesis
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 are Tolerated and Act in the Body in Healthy Adults
Pfizer Australia Pty Ltd
IgA nephropathy
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-07999415 are Tolerated and Act in the Body in Healthy Adults
Pfizer Australia Pty Ltd
CCI
1 trial -
A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 are Tolerated and Act in the Body of Healthy Adults
Pfizer Australia Pty Ltd
Rheumatoid arthritis and Systemic Lupus Erythematosus
1 trial -
A Study to Learn How Different Forms of The Study Medicine Called Prazosin Are Taken up Into the Blood in Healthy Adults
Pfizer Australia Pty Ltd
Primary and secondary hypertension, and heart failure
1 trial -
A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin® (somatropin) Delivery and Taken Up Into the Blood in Healthy Adults
Pfizer Australia Pty Ltd
Growth hormone deficiency
1 trial -
A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed by the Body in Men With Prostate Cancer
Astellas Pharma GmbH
Hot Flush
1 trial -
A Study to Learn How a Tablet Compared with an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up into the Blood in Healthy Adults.
Pfizer Australia Pty Ltd
ER+/HER2- breast cancer
1 trial -
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up into the Blood of Healthy Adults After Taking Different Tablets of the Study Medicine Called Ibuzatrelvir.
Pfizer Australia Pty Ltd
Coronavirus disease 2019
1 trial -
A Study to Learn If The Study Medicine Called Fluconazole Changes How the Body Processes The Other Study Medicine PF-07248144
Pfizer Australia Pty Ltd
locally advanced or metastatic HR+/HER2- breast cancer
1 trial -
A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam
Pfizer Australia Pty Ltd
ER+/HER2 positive breast cancer
1 trial -
A Study to Learn More About an Investigational Medicine called HDP-102 in Patients with Relapsed/Refractory B-cell Blood Cancers.
Lacuna Pharma Pty Ltd
Relapsed/Refractory B-cell Malignancies
1 trial -
A Study to Learn how Various Tablets of the Study Medicine Called Vepdegestrant are Taken up into the Blood in Healthy Adults
Pfizer Australia Pty Ltd
ER+/HER2- Breast Cancer
1 trial -
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144
Pfizer Australia Pty Ltd
locally advanced or metastatic ER+/HER2- breast cancer
1 trial -
A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults
Pfizer Australia Pty Ltd
Type 2 Diabetes Mellitus, Obesity, Overweight management
1 trial -
A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking Ezabenlimab
Boehringer Ingelheim
non-small cell lung cancer or, melanoma, head and neck squamous cell carcinoma
1 trial -
A Study to Test How Safe, Effective and How Body’s Responds to the Combination of Mosunetuzumab and Pirtobrutinib Together to Treat Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Hoffmann-La Roche
Relapsed or Refractory Chronic Lymphocytic Leukemia (R/R CLL)
1 trial -
A Study to Track How the Healthy Male Participants Handles the New Oral Drug RO7795081 for Weight Management and Diabetes
Hoffmann-La Roche
Not Applicable
1 trial -
A Study to Understand What the Body Does to the Study Medicine Called PF-07976016 When Taken by Healthy Adults
Pfizer Australia Pty Ltd
Obesity, Overweight
1 trial -
A Study to assess the Safety, Tolerability and effect of RO7673396 when used alone as well as with other cancer medications in participants with Advanced Solid Tumors
Hoffmann-La Roche
Advanced Solid Tumors Harboring RAS Mutation(S)
1 trial -
A Study to evaluate the effect of a high-fat meal on the Pharmacokinetics of the Selective MET kinase Inhibitor DO-2 in subjects in good health
Wuhan Createrna Science and Technology Co., Ltd
Healthy volunteer
1 trial -
A Study to find out the safety, tolerability and interaction of drug with body (including the effect of Itraconazole on RO7268489) and also what the body does to RO7268489 after oral intake by healthy participants
Hoffmann-La Roche
Not applicable
1 trial -
A Study to see how safe is RO7567132 as Single Agent and in Combination with Atezolizumab, how the body gets rid of it and how effective it is in people with Advanced and/or Metastatic Solid Tumors
Hoffmann-La Roche
Advanced and/or Metastatic Solid Tumors
1 trial -
A Study with ABBV-155 Alone and in Combination with Taxane Therapy in Adults with Relapsed and/or Refractory Solid Tumors
AbbVie Deutschland GmbH & Co. KG
Patients with relapsed or refractory solid tumors, including: Small cell lung cancer (SCLC); Non-small cell cancer (NSCLC); Breast cancer
1 trial -
A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants
Merck Sharp and Dohme
Healthy
1 trial -
A TWO-PART ABSOLUTE BIOAVAILABILITY STUDY DESIGNED TO EVALUATE THE PHARMACOKINETIC PROFILE OF VELUSETRAG FOLLOWING SINGLE-DOSE ADMINISTRATION OF INTRAVENOUS AND ORAL CAPSULE FORMULATIONS IN HEALTHY MALE AND FEMALE SUBJECTS
Alfasigma S.p.A.
chronic intestinal pseudo-obstruction (CIPO)
1 trial -
A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of Dapiglutide
Zealand Pharma A/S
Weight management
1 trial -
A Trial to Determine if Quabodepistat is Processed Differently in Adults with Reduced Liver Function Compared to Adults with Normal Liver Function
Otsuka Beijing Research Institute
Tuberculosis
1 trial -
A Trial to Evaluate Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR4 Compared with Insulin Degludec and Insulin Icodec in Participants with Type 2 Diabetes
Lacuna Pharma Pty Ltd
Type 2 Diabetes Mellitus
1 trial -
A Trial to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Insulin GZR33 Compared with Insulin Degludec at steady state in participants with Type 1 Diabetes
Lacuna Pharma Pty Ltd
Type 1 diabetes Mellitus
1 trial -
A Trial to Examine the Effects of MSP-2020 on Brain Activity in Healthy Adults
Otsuka Beijing Research Institute
Incomplete Response - Major Depressive Disorder (IR-MDD)
1 trial -
A bioavailability study of epinephrine following a single dose of emergency response auto-injector in comparison to epinephrine injection into muscle via syringe in healthy adults.
Mylan Pharma UK
Allergic reactions (Type 1), including anaphylaxis, idiopathic anaphylaxis or exercise-induced anaphylaxis
1 trial -
A clinical research study investigating how the body processes the new compound petrelintide in people with kidney problems
Zealand Pharma A/S
Weight management
1 trial -
A clinical study of MK-0472 in people with solid tumors (MK-0472-001)
Merck Sharp and Dohme
Malignant Neoplasm - Solid Tumors
1 trial
Frequently asked questions
How many Phase I pipeline programs are in the directory?
4,713 published programs match this development stage in our ClinicalTrials.gov index.
What defines this pipeline stage?
Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.
Data attribution: Data sources · All pipeline programs